Merus (MRUS) News Today $50.01 -0.79 (-1.56%) Closing price 04:00 PM EasternExtended Trading$49.98 -0.03 (-0.07%) As of 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MRUS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Merus (NASDAQ:MRUS) Shares Down 3.1% - Should You Sell?Merus (NASDAQ:MRUS) Stock Price Down 3.1% - Here's WhyMay 28 at 1:29 PM | marketbeat.comPolar Asset Management Partners Inc. Buys Shares of 31,354 Merus (NASDAQ:MRUS)Polar Asset Management Partners Inc. bought a new stake in Merus (NASDAQ:MRUS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 31,354 shares of the biotechnology company's stock, valued at apprMay 28 at 5:36 AM | marketbeat.comMerus (NASDAQ:MRUS) Receives Consensus Recommendation of "Buy" from AnalystsShares of Merus (NASDAQ:MRUS - Get Free Report) have been given a consensus rating of "Buy" by the sixteen analysts that are currently covering the firm, MarketBeat.com reports. Fourteen analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the cMay 28 at 1:47 AM | marketbeat.comMerus to Present at Upcoming Investor ConferencesMay 27 at 8:00 AM | globenewswire.comMerus (MRUS) Price Target Raised at BMO After Positive Phase 2 DataMay 26 at 2:18 PM | finance.yahoo.comNorthern Trust Corp Has $3.21 Million Stake in Merus (NASDAQ:MRUS)Northern Trust Corp increased its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 61.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 76,335 shares of the biotechnology company's stockMay 26 at 3:02 AM | marketbeat.comBMO Capital Markets Boosts Merus (NASDAQ:MRUS) Price Target to $110.00May 26 at 1:59 AM | americanbankingnews.comMerus Stock Short Interest Report | NASDAQ:MRUS | BenzingaMay 26 at 12:46 AM | benzinga.comBofA Maintains Buy Rating on Merus (MRUS), Lifts PTMay 25 at 4:49 PM | insidermonkey.comBofA Maintains Buy Rating on Merus (MRUS), Lifts PTMay 25 at 4:28 PM | finance.yahoo.comMerus (NASDAQ:MRUS) Shares Gap Up After Analyst UpgradeMerus (NASDAQ:MRUS) Shares Gap Up on Analyst UpgradeMay 25 at 11:45 AM | marketbeat.comMerus (NASDAQ:MRUS) Stock Price Expected to Rise, BMO Capital Markets Analyst SaysBMO Capital Markets lifted their price objective on Merus from $96.00 to $110.00 and gave the company an "outperform" rating in a research report on Friday.May 25 at 11:05 AM | marketbeat.comMerus (MRUS) Price Target Raised at BMO After Positive Phase 2 DataMay 25 at 5:54 AM | insidermonkey.comMerus (MRUS) Receives a Buy from Truist FinancialMay 25 at 1:19 AM | theglobeandmail.comMerus (NASDAQ:MRUS) Shares Gap Up Following Analyst UpgradeMay 25 at 1:15 AM | americanbankingnews.comStock Traders Purchase High Volume of Call Options on Merus (NASDAQ:MRUS)Merus (NASDAQ:MRUS - Get Free Report) was the recipient of unusually large options trading activity on Thursday. Traders purchased 5,083 call options on the company. This is an increase of 1,320% compared to the average volume of 358 call options.May 24, 2025 | marketbeat.comTwo Sigma Investments LP Lowers Position in Merus (NASDAQ:MRUS)Two Sigma Investments LP lessened its stake in shares of Merus (NASDAQ:MRUS - Free Report) by 14.4% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 507,741 shares of the biotechnology company's stock after selling 85,298 shares during the period. Two Sigma IMay 24, 2025 | marketbeat.comMerus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCCMay 23, 2025 | finance.yahoo.comMerus Stock Climbs on Positive Trial ResultsMay 23, 2025 | marketwatch.comMerus gains after mid-stage trial data for lead asset in head and neck cancerMay 23, 2025 | msn.comMerus updates on Petosemtamab+Pembrolizumab data in HNSCCMay 23, 2025 | finance.yahoo.comMerus Stock Surges Over 35% On Strong Phase 2 Cancer Trial Results: What's Going On?May 23, 2025 | benzinga.comMerus Stock Soars On Positive Phase 2 Drug Trial Data, Price Target Hikes: Retail’s ThrilledMay 23, 2025 | msn.comMRUS: BMO Capital Raises Price Target for Merus to $110 | MRUS Stock NewsMay 23, 2025 | gurufocus.comFrontline, Merus, Intuit And Other Big Stocks Moving Higher On FridayMay 23, 2025 | benzinga.comMerus’ Potential ‘Best-In-Class’ Cancer Treatment Bolsters MRUS Stock 30%May 23, 2025 | tipranks.comPromising Potential of Merus’s Petosemtamab: A Buy Rating Backed by Impressive Efficacy and SafetyMay 23, 2025 | tipranks.comTwo Sigma Advisers LP Has $30.31 Million Holdings in Merus (NASDAQ:MRUS)Two Sigma Advisers LP decreased its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 1.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 720,800 shares of the biotechnology company's stock after selling 9,000 sharesMay 23, 2025 | marketbeat.comInvestors Buy Large Volume of Call Options on Merus (NASDAQ:MRUS)May 23, 2025 | americanbankingnews.comMerus N.V. Reports Positive Interim Clinical Data for Petosemtamab in Combination with Pembrolizumab in Head and Neck CancerMay 22, 2025 | quiverquant.comMerus' Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCCMay 22, 2025 | globenewswire.comVR Adviser LLC Decreases Position in Merus (NASDAQ:MRUS)VR Adviser LLC lowered its stake in shares of Merus (NASDAQ:MRUS - Free Report) by 34.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 592,411 shares of the biotechnology company's stock after selling 315,552May 22, 2025 | marketbeat.comMerus' (MRUS) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and issued a $75.00 price target on shares of Merus in a research report on Monday.May 21, 2025 | marketbeat.comSoleus Capital Management L.P. Sells 86,000 Shares of Merus (NASDAQ:MRUS)Soleus Capital Management L.P. decreased its position in Merus (NASDAQ:MRUS - Free Report) by 21.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 312,321 shares of the biotechnology company's stock after selling 86,000 shares during the periMay 21, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Purchased by Wexford Capital LPWexford Capital LP boosted its position in Merus (NASDAQ:MRUS - Free Report) by 26.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,386 shares of the biotechnology company's stock after purchasingMay 21, 2025 | marketbeat.comOMERS ADMINISTRATION Corp Takes Position in Merus (NASDAQ:MRUS)OMERS ADMINISTRATION Corp bought a new position in shares of Merus (NASDAQ:MRUS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 10,600 shares of the biotechnology company's stock, valued at approximateMay 21, 2025 | marketbeat.comMillennium Management LLC Grows Position in Merus (NASDAQ:MRUS)Millennium Management LLC lifted its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 87.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 883,565 shares of the biotechnology company's stock after buyiMay 20, 2025 | marketbeat.comPromising Outlook for Merus’s Petosemtamab in HNSCC Treatment Drives Buy RatingMay 19, 2025 | tipranks.comMerus (NASDAQ:MRUS) Position Decreased by Sphera Funds Management LTD.Sphera Funds Management LTD. decreased its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 11.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 130,532 shares of the biotechnology compaMay 18, 2025 | marketbeat.comPolar Capital Holdings Plc Purchases 439,186 Shares of Merus (NASDAQ:MRUS)Polar Capital Holdings Plc grew its position in Merus (NASDAQ:MRUS - Free Report) by 34.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,706,238 shares of the biotechnology company's stock after buying an additional 439,186 shares during the period. PolaMay 17, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Sold by Paradigm Biocapital Advisors LPParadigm Biocapital Advisors LP lowered its stake in Merus (NASDAQ:MRUS - Free Report) by 31.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,689,922 shares of the biotechnology company's stock after selling 764,995 sMay 16, 2025 | marketbeat.comBalyasny Asset Management L.P. Cuts Stock Holdings in Merus (NASDAQ:MRUS)Balyasny Asset Management L.P. lowered its stake in shares of Merus (NASDAQ:MRUS - Free Report) by 94.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,399 shares of the biotechnology company's stockMay 16, 2025 | marketbeat.comMerus Announces the Journal Publication of Petosemtamab Mechanism of ActionMay 15, 2025 | globenewswire.comOctagon Capital Advisors LP Invests $12.95 Million in Merus (NASDAQ:MRUS)Octagon Capital Advisors LP acquired a new position in shares of Merus (NASDAQ:MRUS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 308,000 shares of the biotechnology company's stock,May 15, 2025 | marketbeat.comJ. Goldman & Co LP Sells 33,499 Shares of Merus (NASDAQ:MRUS)J. Goldman & Co LP lessened its stake in Merus (NASDAQ:MRUS - Free Report) by 82.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,001 shares of the biotechnology company's stock after selling 33,499 shares during the quaMay 15, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Lowers Stock Position in Merus (NASDAQ:MRUS)D. E. Shaw & Co. Inc. lessened its stake in Merus (NASDAQ:MRUS - Free Report) by 45.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 359,048 shares of the biotechnology company's stoMay 15, 2025 | marketbeat.comBNP Paribas Financial Markets Has $7.89 Million Stock Position in Merus (NASDAQ:MRUS)BNP Paribas Financial Markets decreased its stake in shares of Merus (NASDAQ:MRUS - Free Report) by 3.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 187,548 shares of the biotechnologMay 14, 2025 | marketbeat.comGranahan Investment Management LLC Sells 8,689 Shares of Merus (NASDAQ:MRUS)Granahan Investment Management LLC decreased its position in shares of Merus (NASDAQ:MRUS - Free Report) by 7.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 104,562 shares of the biotechnology company's stock after selling 8,689 shares during the quarterMay 13, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Sold by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company decreased its position in Merus (NASDAQ:MRUS - Free Report) by 17.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 42,085 shares of the biotechnology company'May 13, 2025 | marketbeat.comHC Wainwright Has Pessimistic Outlook of Merus Q2 EarningsMerus (NASDAQ:MRUS - Free Report) - Equities researchers at HC Wainwright lowered their Q2 2025 earnings per share estimates for Merus in a research report issued on Thursday, May 8th. HC Wainwright analyst A. Fein now anticipates that the biotechnology company will earn ($1.28) per share for theMay 13, 2025 | marketbeat.com Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address MRUS Media Mentions By Week MRUS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRUS News Sentiment▼0.801.03▲Average Medical News Sentiment MRUS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRUS Articles This Week▼356▲MRUS Articles Average Week Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Intra-Cellular Therapies News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Moderna News Today Ascendis Pharma A/S News Today Viatris News Today Qiagen News Today Roivant Sciences News Today Revolution Medicines News Today Blueprint Medicines News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRUS) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merus Please log in to your account or sign up in order to add this asset to your watchlist. Share Merus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRUS Stock Free MRUS Stock Alerts